Nutrien rises after Morgan Stanley upgrades US-listed shares to 'overweight'

Nutrien

14/01/2026 15:05

Updates

** U.S.-listed shares of Canadian agrichemical company Nutrien NTR.N NTR.TO hit their highest since September 2023, last up 5.6% at $64.8

** Morgan Stanley upgrades U.S.-listed NTR shares to "overweight" from "equal-weight"

** Raises PT to $77 from $70, implying a 25.6% upside to stock's last close

** Morgan Stanley expects moderate potash price increases in 2026, with global potash effective capacity utilization rate remaining above 90% until at least 2028

** Higher potash price forecasts push its EBITDA estimate ~12% above consensus - brokerage

** 14 out of 24 brokerages rate stock "buy" or higher, 8 "hold" and 2 "sell"; median PT is $66.20 - data compiled by LSEG

** Shares up 37.9% in 2025

(Reporting by Sumit Saha in Bengaluru)

((Sumit.Saha@thomsonreuters.com;))